ArticlePloS one2026

Superior diagnostic efficacy and cost advantage of FibroTouch over CHI3L1 for liver fibrosis in Chinese patients with chronic liver disease.

Zhongbao Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.